Evidence map›Paper›PMID 42282022›Full record

ArticleResearch square2026

HIRA-mediated H3.3 deposition preserves hepatocyte cell identity during liver aging.

Peter Adams, Rouven Arnold, Marcos Teneche, Xue Lei, Armin Gandhi, Christina Shi, Jessica Proulx, Adarsh Rajesh, Aaron Havas, Shiqi Su and 28 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Peter AdamsSanford Burnham Prebys Medical Discovery Institute.ORCID 0000-0002-0684-1770
Rouven ArnoldSanford Burnham Prebys Medical Discovery Institute.
Marcos TenecheSanford Burnham Prebys Medical Discovery Institute.ORCID 0000-0003-4785-7987
Xue LeiSanford Burnham Prebys MDI.
Armin GandhiSanford Burnham Prebys Medical Discovery Institute.ORCID 0000-0002-8246-4663
Christina ShiSanford Burnham Prebys Medical Discovery Institute.
Jessica ProulxSanford Burnham Prebys Medical Discovery Institute.
Adarsh RajeshSanford Burnham Prebys Medical Discovery Institute.
Aaron HavasSanford Burnham Prebys Medical Discovery Institute.ORCID 0000-0003-4291-8015
Shiqi SuSanford Burnham Prebys Medical Discovery Institute.
Annanya SethiyaSanford Burnham Prebys Medical Discovery Institute.
Shanshan YinSanford Burnham Prebys Medical Discovery Institute.
Hiroshi TanakaSanford Burnham Prebys Medical Discovery Institute.
Zong ChuaSanford Burnham Prebys Medical Discovery Institute.
Andrew DavisSanford Burnham Prebys Medical Discovery Institute.
Laurence HaddadinSanford Burnham Prebys Medical Discovery Institute.ORCID 0009-0006-2359-4288
Michael AlcarazSanford Burnham Prebys Medical Discovery Institute.
Irene HuangSanford Burnham Prebys Medical Discovery Institute.
Angela LiouSanford Burnham Prebys Medical Discovery Institute.
Anaïs EqueyUniversity of Liverpool.
Nirmalya DasguptaLa Jolla Institute of Immunology.
Karl MillerSanford Burnham Prebys Medical Discovery Institute.
Margaret TulessinTechnical University Munich (TUM).ORCID 0009-0009-3854-5288
Buddy CharbonoSanford Burnham Prebys Medical Discovery Institute.
Adriana CharbonoSanford Burnham Prebys Medical Discovery Institute.
Siva VaranasiSalk Institute for Biological Studies.
K EvensenSalk Institute for Biological Studies.
April Williams WehnerSalk Institute for Biological Studies.ORCID 0000-0001-9281-8528
Rebecca PorrittSanford Burnham Prebys Medical Discovery Institute.ORCID 0000-0002-0973-5092
Guillermina GarciaSanford Burnham Prebys MDI.
Sakshi ChauhanNational Institutes of Health.
Brian EganActive Motif.
Michael ChoobActive Motif, Inc.
Carolin MoglerTU Munich.ORCID 0000-0003-3400-7254
Kevin Y YipSanford Burnham Prebys Medical Discovery Institute.ORCID 0000-0001-5516-9944
Keiko OzatoNational Institutes of Health.
Susan KaechSalk Institute for Biological Studies.ORCID 0000-0003-1674-1420
Yu Xin WangSanford Burnham Prebys Medical Discovery Institute.

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Alan Saghatelian · 1985 to 2026
$82.8M
STRUCTURAL BASIS FOR EPIGENETICS IN AGING AND LONGEVITYP01AG031862 · NIA · WISTAR INSTITUTE · PI SCHULTZ, DAVID C · 2008 to 2022
$28.3M
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapyP01AG073084 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PETER D. ADAMS, GERALD SHADEL · 2021 to 2026
$13.6M
San Diego Nathan Shock CenterP30AG068635 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SHADEL, GERALD · 2020 to 2024
$6.0M
A high-resolution tribrid mass spectrometer to amplify bioanalytical capacity at Salk Institute Mass Spectrometry coreS10OD038262 · OD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI METALLO, CHRISTIAN MICHAEL · 2025 to 2025
$1.2M
A Hybrid Quadrupole-Orbitrap LC/MSS10OD021815 · OD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SAGHATELIAN, ALAN · 2016 to 2016
$580k
Mitonuclear signaling pathways in senescence-associated inflammationK99AG073450 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MILLER, KARL NATHAN · 2022 to 2023
$236k
NCI NIH HHS P30 CA014195NCI NIH HHS P30 CA030199NIA NIH HHS K99 AG073450NIA NIH HHS P01 AG031862NIA NIH HHS P01 AG073084NIA NIH HHS P30 AG068635NIH HHS S10 OD021815NIH HHS S10 OD038262
6 · The paper itself

Abstract

Age-associated functional decline is partly driven by progressive chromatin degeneration. Maintenance of chromatin integrity preserves cell identity and promotes healthy aging, but through different mechanisms in proliferating and non-proliferating cells. However, specific mechanisms of chromatin maintenance and their compensatory capacity in proliferating and non-proliferating cells are undefined. The histone chaperone HIRA deposits the histone variant H3.3 in a DNA replication-independent manner, leading to its accumulation in aging, non-proliferating cells. Here, we show that hepatocyte-specific loss of HIRA causes loss of cell identity, metabolic dysfunction, and accelerated fibrotic pathology with age. Transcriptomic and epigenomic analyses indicate that HIRA-H3.3 preserves chromatin integrity and sustains transcription of highly expressed genes, including cell identity genes. Partial hepatectomy, associated with induced proliferation, restores identity of HIRA knockout livers with compensatory deposition of canonical histones H3.1/2. Together, these results demonstrate that HIRA-mediated H3.3 deposition is essential for safeguarding cell identity and tissue function during aging of non-proliferating cells, but this function can be rescued by tissue regeneration and associated cell proliferation.

Identifiers

PMID42282022
PMCPMC13252554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.